| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 07/18/2002 | WO2002055501A2 N-pyridyl carboxamide derivatives and pharmaceutical compositions containing them |
| 07/18/2002 | WO2002055492A2 An improved process for preparing pure ondansetron hydrochloride dihydrate |
| 07/18/2002 | WO2002055101A2 Storage stable powder compositions of interleukin-4 receptor |
| 07/18/2002 | WO2002055099A2 Modulation of pericyte proliferation using bpi protein products or bpi inhibitors |
| 07/18/2002 | WO2002055091A1 Antiallergic agents |
| 07/18/2002 | WO2002055087A1 Dihydro-triterpenes in the treatment of viral infections, cardiovascular disease, inflammation, hypersensitivity or pain |
| 07/18/2002 | WO2002055077A1 Use of imidazolyl cyclic acetal derivatives in the manufacture of a medicament for the treatment of diseases mediated by the alk5 receptors |
| 07/18/2002 | WO2002055075A2 Compounds and methods for regulating cell differentiation |
| 07/18/2002 | WO2002055067A2 Fumaric acid derivatives as nf-kappab inhibitors |
| 07/18/2002 | WO2002055066A1 Fumaric acid derivatives as nf-kappa-b inhibitors |
| 07/18/2002 | WO2002055065A2 Use of an ltb4 antagonist for the treatment and/or prevention of diseases caused by increased expression of mucin genes |
| 07/18/2002 | WO2002055063A2 Fumaric acid amides |
| 07/18/2002 | WO2002034202A3 Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress |
| 07/18/2002 | WO2002022558A3 2-amino-2-alkyl-3 heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors |
| 07/18/2002 | WO2002012249A3 Substituted pyrrole compounds and their use as spla2 inhibitors |
| 07/18/2002 | WO2002006316A3 Alpha-msh related compounds and methods of use |
| 07/18/2002 | WO2002002633A3 Transporters and ion channels |
| 07/18/2002 | WO2002002556A3 AZA-BRIDGED-BICYCLIC AMINO ACID DERIVATIVES AS α4 INTEGRIN ANTAGONISTS |
| 07/18/2002 | WO2001096299A3 Indole derivatives and their use as 15-lipoxygenase inhibitors |
| 07/18/2002 | WO2001094391A3 Intracellular signaling proteins |
| 07/18/2002 | WO2001094345A3 Derivatives of 2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione |
| 07/18/2002 | WO2001090103A3 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as protein kinase modulators |
| 07/18/2002 | WO2001081590A3 Protein phosphatases |
| 07/18/2002 | WO2001079282A3 Molecules associated with human reproduction |
| 07/18/2002 | WO2001072728A3 Novel piperazine derivatives |
| 07/18/2002 | WO2001066747A3 Proteins named fctrx and nucleic acids encoding same |
| 07/18/2002 | WO2001005834A9 Human tumor necrosis factor receptors tr13 and tr14 |
| 07/18/2002 | US20020095024 B7-related nucleic acids and polypeptides useful for immunomodulation |
| 07/18/2002 | US20020095023 Membrane protein for use in the treatment of allergies, parkinson's, alzheimer's and apoptitic defects |
| 07/18/2002 | US20020094994 Pyrrolidine carboxylic Acid or ester derivatives are useful for treating alpha 4 beta 1 mediated cell adhesion |
| 07/18/2002 | US20020094987 Amide or thioamide substituted benzimidazole or quinoxaline derivatives; therapeutic utility via inhibition of tumor necrosis factor or phosphodiesterase |
| 07/18/2002 | US20020094980 Preparing 1,1-dioxo-2-phenyl-3-carboxy-4-phenyl-1,2-benzo(e)-thiazines by a five-step process starting with a (2-(methyl-oxycarbonyl-)phenyl-sulfonamido-)benzene; alkylation; cyclization; hydroxylation; esterification and coupling |
| 07/18/2002 | US20020094338 Intranasal delivery of pneumococcal polysaccharide vaccines |
| 07/18/2002 | US20020094328 Combination of lactic acid bacteria and its use for the prevention and/or treatment of infections and inflammatory conditions |
| 07/18/2002 | CA2776023A1 Fumaric acid amides |
| 07/18/2002 | CA2434574A1 An antiallergic agent |
| 07/18/2002 | CA2434274A1 N-pyridyl carboxamide derivatives and pharmaceutical compositions containing them |
| 07/18/2002 | CA2433720A1 An improved process for preparing pure ondansetron hydrochloride dihydrate |
| 07/18/2002 | CA2433451A1 Use of an ltb4 antagonist for the treatment and/or prevention of diseases caused by increased expression of mucin genes |
| 07/18/2002 | CA2433084A1 1-(2-methoxybenzyl)-3-benzhydrylpiperazines as tachykinin antagonists |
| 07/18/2002 | CA2432114A1 4-(hetero)aryl substituted indolinones |
| 07/18/2002 | CA2430588A1 Modulation of pericyte proliferation using bpi protein products or bpi inhibitors |
| 07/18/2002 | CA2428075A1 Fumaric acid derivatives as nf-kappab inhibitors |
| 07/17/2002 | EP1223170A1 Pyrimidine-5-carboxamide compounds, process for producing the same and use thereof |
| 07/17/2002 | EP1222463A2 Allosteric sites on muscarinic receptors |
| 07/17/2002 | EP1222270A2 Proteins and polynucleotides encoded thereby |
| 07/17/2002 | EP1222253A1 Retinoid receptor interacting polynucleotides, polypeptides, and antibodies |
| 07/17/2002 | EP1222212A1 Il13 mutants |
| 07/17/2002 | EP1222209A2 Modulation of t cell differentiation for the treatment of t helper cell mediated diseases |
| 07/17/2002 | EP1222203A1 Method of altering polypeptide aggregation |
| 07/17/2002 | EP1222200A1 Vaccine |
| 07/17/2002 | EP1222195A1 Novel thiazolo(4,5-d)pyrimidine compounds |
| 07/17/2002 | EP1222193A2 Imidazole derivatives as phosphodiesterase vii inhibitors |
| 07/17/2002 | EP1222191A2 Benzodiazepin derivatives, the production and use thereof |
| 07/17/2002 | EP1222187A2 Heterocyclic compounds useful as inhibitors of tyrosine kinases |
| 07/17/2002 | EP1222182A2 Substituted (aminoiminomethyl or aminomethyl) dihydrobenzofurans and benozopyrans |
| 07/17/2002 | EP1222162A1 Novel ltb 4? antagonist, method for the production thereof and its use as a medicament |
| 07/17/2002 | EP1221976A1 Low dose ifn-gamma for treatment of disease |
| 07/17/2002 | EP1221955A2 Immunostimulatory nucleic acids |
| 07/17/2002 | EP1221953A1 Treating sleep disorders using desloratadine |
| 07/17/2002 | EP1221949A2 Method and composition for prophylaxis and treatment of symptoms associated with cold and influenza-like illnesses |
| 07/17/2002 | EP1221852A2 Antimicrobial compositions comprising a benzoic acid analog and a metal salt |
| 07/17/2002 | EP1073440A4 sPLA 2 INHIBITOR ESTER |
| 07/17/2002 | EP0888340B1 4-(benzo-1,3-dioxolyl)-pyrrolidine-3-carboxylic acid derivatives as endothelin antagonists |
| 07/17/2002 | EP0882044B1 1,4-dihydropyridine compounds as bradykinin antagonists |
| 07/17/2002 | EP0830374B1 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases |
| 07/17/2002 | EP0766668B1 Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudormophs thereof |
| 07/17/2002 | CN1359376A Carboxylic acid derivatives compriosing aryl-substituted nitrogen heterocycles, their production and their use as endothel in receptor antagonists |
| 07/17/2002 | CN1359288A Method for improvement of transport across adaptable semi-permeable barriers |
| 07/17/2002 | CN1358534A Compound medicine for treating bronchial asthma and preparation process |
| 07/17/2002 | CN1087737C Dihygropyridine derivatives as bradykinin ant agonists |
| 07/17/2002 | CN1087624C Chinese-medicina decoction for treating lung diseases |
| 07/17/2002 | CN1087623C Antipyretic granular formulation containing remulus cinnamoni, ephedra and bupleurum root |
| 07/17/2002 | CN1087618C Medicine for treating allergic rhinitis |
| 07/16/2002 | US6420600 Hydroxyalkylphenyldiamides |
| 07/16/2002 | US6420591 Carbamates and compositions thereof, and methods for their use for treating cancer, inflammation, or a viral infection |
| 07/16/2002 | US6420567 Prodrugs |
| 07/16/2002 | US6420561 Piperazinyl or piperidinyl acid derivatives for treatment of rheumatic diseases, arthritis due to gout and antiinflammatory agents |
| 07/16/2002 | US6420424 CCR-3 receptor antagonists |
| 07/16/2002 | US6420393 Nuclear factor .kappa.b-dependent disease selected from the group consisting of inflammatory diseases, immunological disorders, septic shock, transplant rejection, radiation damage, reperfusion injuries after ischemia, stroke or |
| 07/16/2002 | US6420392 Paf receptor antagonists and/or by inhibiting the enzyme 5-lipoxygenase. |
| 07/16/2002 | US6420385 Substituted pyrimidinone and pyridone compounds and methods of use |
| 07/16/2002 | US6420383 Calcium channel blockers, hypersensitivity, allergy, asthma, bronchospasm, dysmenorrhea, esophageal spasm, glaucoma, premature labor, urinary tract disorders, gastrointestinal motility disorders and cardiovascular disorders. |
| 07/16/2002 | US6420373 9-N-Bicyclic nuceoside agents useful as selective inhibitors of proinflammatory cytokines |
| 07/16/2002 | US6420364 Treating autoimmune diseases,alzheimer's disease, atherosclerosis, osteoporosis, |
| 07/16/2002 | US6420150 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| 07/16/2002 | CA2131383C Wound healing and treatment of fibrotic disorders |
| 07/16/2002 | CA2125666C Medicaments |
| 07/11/2002 | WO2002053733A2 Regulation of human b7-h2 protein |
| 07/11/2002 | WO2002053565A1 Tricyclic and heterocyclic derivative compounds and drugs containing these compounds as the active ingredient |
| 07/11/2002 | WO2002053564A2 Quinuclidine derivatives and their use as m3 antagonists |
| 07/11/2002 | WO2002053557A1 Novel sulfamides and their use as endothelin receptor antagonists |
| 07/11/2002 | WO2002053544A1 Pharmaceutical uses and synthesis of nicotinanilide-n-oxides |
| 07/11/2002 | WO2002053534A1 Vla-4 inhibitors |
| 07/11/2002 | WO2002053519A2 Hydrophobic polyamine analogs and methods for their use |
| 07/11/2002 | WO2002053100A2 Pharmaceutical dosage form for oral administration of low molecular weight heparin |
| 07/11/2002 | WO2002028349A3 Method of treating cancer using dithiocarbamate derivatives |
| 07/11/2002 | WO2002024658A3 Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists |
| 07/11/2002 | WO2002024657A3 Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists |
| 07/11/2002 | WO2002017914A8 Fused pyrrolocarbazoles against inflammation |